{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:47:49Z","timestamp":1782409669805,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10147-026-03058-3","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:55:14Z","timestamp":1779900914000},"page":"1399-1407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative evaluation of healthcare information provided to patients with thoracic malignancies: patient satisfaction survey of the Japan Lung Cancer Society"],"prefix":"10.1007","volume":"31","author":[{"given":"Takayuki","family":"Takahama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehito","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Aono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Ohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Akiho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatoe","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiichiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mitsudomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0705-3781","authenticated-orcid":false,"given":"Toshiyuki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"8936","key":"3058_CR1","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(94)90386-7","volume":"344","author":"L Fallowfield","year":"1994","unstructured":"Fallowfield L, Ford S, Lewis S (1994) Information preferences of patients with cancer. Lancet 344(8936):1576. https:\/\/doi.org\/10.1016\/S0140-6736(94)90386-7","journal-title":"Lancet"},{"key":"3058_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cco.0000167734.26454.30","author":"A Br\u00e9dart","year":"2005","unstructured":"Br\u00e9dart A, Bouleuc C, Dolbeault S (2005) Doctor\u2013patient communication and satisfaction with care in oncology. Curr Opin Oncol. https:\/\/doi.org\/10.1097\/01.cco.0000167734.26454.30","journal-title":"Curr Opin Oncol"},{"issue":"8843","key":"3058_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/0140-6736(93)90219-7","volume":"341","author":"L Fallowfield","year":"1993","unstructured":"Fallowfield L (1993) Giving sad and bad news. Lancet 341(8843):476\u2013478. https:\/\/doi.org\/10.1016\/0140-6736(93)90219-7","journal-title":"Lancet"},{"issue":"4","key":"3058_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1634\/theoncologist.5-4-302","volume":"5","author":"WF Baile","year":"2000","unstructured":"Baile WF, Buckman R, Lenzi R et al (2000) SPIKES\u2014A six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5(4):302\u2013311. https:\/\/doi.org\/10.1634\/theoncologist.5-4-302","journal-title":"Oncologist"},{"issue":"2","key":"3058_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0738-3991(96)00908-1","volume":"29","author":"C de Valck","year":"1996","unstructured":"de Valck C, van de Woestijne KP (1996) Communication problems on an oncology ward. Patient Educ Couns 29(2):131\u2013136. https:\/\/doi.org\/10.1016\/0738-3991(96)00908-1","journal-title":"Patient Educ Couns"},{"key":"3058_CR6","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN guidelines for patients. https:\/\/www.nccn.org\/patientresources\/patient-resources\/guidelines-for-patients"},{"key":"3058_CR7","unstructured":"European Society for Medical Oncology (ESMO). Cancer guides for patients. https:\/\/www.esmo.org\/for-patients\/patient-guides"},{"key":"3058_CR8","unstructured":"Search results. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=INFO25"},{"issue":"3","key":"3058_CR9","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.je.2016.12.010","volume":"27","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Ukawa S, Okada E et al (2017) Characteristics and prognosis of Japanese male and female lung cancer patients: the BioBank Japan Project. J Epidemiol 27(3):S49\u2013S57. https:\/\/doi.org\/10.1016\/j.je.2016.12.010","journal-title":"J Epidemiol"},{"issue":"2","key":"3058_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jtho.2018.10.002","volume":"14","author":"J Okami","year":"2019","unstructured":"Okami J, Shintani Y, Okumura M et al (2019) Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry database in 2010. J Thorac Oncol 14(2):212\u2013222. https:\/\/doi.org\/10.1016\/j.jtho.2018.10.002","journal-title":"J Thorac Oncol"},{"issue":"3","key":"3058_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jtho.2021.11.020","volume":"17","author":"H Horinouchi","year":"2022","unstructured":"Horinouchi H, Kusumoto M, Yatabe Y et al (2022) Lung cancer in Japan. J Thorac Oncol 17(3):353\u2013361. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.020","journal-title":"J Thorac Oncol"},{"issue":"3","key":"3058_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/030089160008600304","volume":"86","author":"A Caruso","year":"2000","unstructured":"Caruso A, di Francesco B, Pugliese P et al (2000) Information and awareness of diagnosis and progression of cancer in adult and elderly cancer patients. Tumori 86(3):199\u2013203. https:\/\/doi.org\/10.1177\/030089160008600304","journal-title":"Tumori"},{"issue":"1","key":"3058_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.critrevonc.2004.04.002","volume":"51","author":"M Pinquart","year":"2004","unstructured":"Pinquart M, Duberstein PR (2004) Information needs and decision-making processes in older cancer patients. Crit Rev Oncol Hematol 51(1):69\u201380. https:\/\/doi.org\/10.1016\/j.critrevonc.2004.04.002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"3058_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12094-011-0674-1","volume":"13","author":"JI Arraras","year":"2011","unstructured":"Arraras JI, Manterola A, Hern\u00e1ndez B et al (2011) The EORTC information questionnaire, EORTC QLQ\u2013INFO25. Validation study for Spanish patients. Clin Transl Oncol 13(6):401\u2013410. https:\/\/doi.org\/10.1007\/s12094-011-0674-1","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"3058_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.pec.2013.03.011","volume":"92","author":"JCM van Weert","year":"2013","unstructured":"van Weert JCM, Bolle S, van Dulmen S et al (2013) Older cancer patients\u2019 information and communication needs: what they want is what they get? Patient Educ Couns 92(3):388\u2013397. https:\/\/doi.org\/10.1016\/j.pec.2013.03.011","journal-title":"Patient Educ Couns"},{"issue":"7","key":"3058_CR16","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00520-012-1450-7","volume":"20","author":"MTE Puts","year":"2012","unstructured":"Puts MTE, Papoutsis A, Springall E et al (2012) A systematic review of unmet needs of newly diagnosed older cancer patients undergoing active cancer treatment. Support Care Cancer 20(7):1377\u20131394. https:\/\/doi.org\/10.1007\/s00520-012-1450-7","journal-title":"Support Care Cancer"},{"issue":"3","key":"3058_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pec.2004.06.006","volume":"57","author":"LJF Rutten","year":"2005","unstructured":"Rutten LJF, Arora NK, Bakos AD et al (2005) Information needs and sources of information among cancer patients: a systematic review of research (1980\u20132003). Patient Educ Couns 57(3):250\u2013261. https:\/\/doi.org\/10.1016\/j.pec.2004.06.006","journal-title":"Patient Educ Couns"},{"issue":"7","key":"3058_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ejca.2011.08.018","volume":"48","author":"C Maddock","year":"2012","unstructured":"Maddock C, Camporesi S, Lewis I et al (2012) Online information as a decision making aid for cancer patients: recommendations from the Eurocancercoms project. Eur J Cancer 48(7):1055\u20131059. https:\/\/doi.org\/10.1016\/j.ejca.2011.08.018","journal-title":"Eur J Cancer"},{"key":"3058_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2020.578792","volume":"2","author":"A Hanai","year":"2020","unstructured":"Hanai A, Morino T, Shinohara Y et al (2020) Satisfaction with Web-based healthcare content in cancer survivors: a cross-sectional survey. Front Digit Health 2:578792. https:\/\/doi.org\/10.3389\/fdgth.2020.578792","journal-title":"Front Digit Health"},{"issue":"1","key":"3058_CR20","doi-asserted-by":"publisher","DOI":"10.1590\/0034-7167-2023-0358","volume":"77","author":"M Bezerra","year":"2024","unstructured":"Bezerra M, De Domenico EBL (2024) Cancer patient satisfaction regarding the quality of information received: psychometric validity of EORTC QLQ\u2011INFO25. Rev Bras Enferm 77(1):e20230358. https:\/\/doi.org\/10.1590\/0034-7167-2023-0358","journal-title":"Rev Bras Enferm"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03058-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:19:15Z","timestamp":1782407955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3058"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03058-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7787251\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Takahama reported receiving grant funding from Takeda Pharmaceutical Company Limited during the conduct of the study and personal fees from AstraZeneca, Chugai Pharmaceutical Co., Roche Diagnostics, and MSD, and grant funding from Pfizer Inc. and Takeda outside the submitted work. Dr Yoshimura reported receiving grant funding from Boehringer Ingelheim and personal fees from Chugai Pharma, AstraZeneca, and Taiho. Dr Horinouchi reported receiving grant funding from AstraZeneca, Roche\/Chugai, MSD, AbbVie, and BMS\/Ono, and personal fees from AstraZeneca, Roche\/Chugai, MSD, Bristol-Myers Squibb\/Ono, and AbbVie. Dr Kaneda reported receiving grant funding from Eli Lilly and personal fees from Chugai, AstraZeneca, MSD, Bristol-Myers Squibb, Novartis Pharma, Eli Lilly, Ono, and Takeda. Dr Watanabe reported receiving grant funding from Pfizer. Dr Hayashi reported receiving grant funding from IQVIA Services JAPAN K.K., Eisai Co., Ltd., SYNEOS HEALTH CLINICAL K.K.EP-CRSU CO., LTD., EPS Corporation, Shionogi & Co., Ltd., Nippon Kayaku Co., Ltd, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., MSD K.K., Sanofi K.K., Amgen Inc., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Bristol Myers Squibb Company, SRL Medisearch Inc., Janssen Pharmaceutical K.K., PRA Health Sciences Inc., CMIC\u3000CO., Ltd., Astellas Pharma Inc., Pfizer R&D Japan G.K., Ascent Development Services, Labcorp Development Japan K.K., Eisai Inc., Kobayashi Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd, Pfizer Japan Inc., AstraZeneca K.K., AbbVie Inc., Daiichi Sankyo Co., Ltd., A2 Healthcare Corp., Novartis Pharma K.K., Eli Lilly Japan K.K., Merck Biopharma Co., Ltd, Medpace Japan K.K., Kyowa Kirin Co., Ltd., Japanese Gastric Cancer Association Thoracic Oncology Research Group, Clinical Research Support Center Kyushu, West Japan Oncology Group, Japan Clinical Caner Research Organization,Comprehensive Support Project for Oncological Research of Breast Cancer, EPS International Co., Ltd,., Mebix, Inc., Ono Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Covance Japan Inc., Japan Clinical Research Operations, Medical Reserch Support and personal fees from Ono Pharmaceutical Co., Ltd., Merck Biopharma Co., Ltd., Daiichi Sankyo Co., Ltd., 3H Clinical Trial Inc., AstraZeneca K.K.,Novartis Pharma K.K., Chugai Pharmaceutical Co., Ltd.Bristol Myers Squibb Company, Eli Lilly Japan K.K., Amgen Inc., MSD K.K., Sysmex Corporation, Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Janssen Pharmaceutical K.K., Guardant Health Japan Corp. Dr Yoshida reported receiving personal fees from DAIICHI SANKYO COMPANY, LIMITED, Hisamitsu Pharmaceutical Co., Inc. Mr Kazuo Hasegawa is paid Chairperson of the Board of advocacy group \u201cLung Cancer Pateient Network ONE STEP\u201d. Dr Oizumi reported receiving grants from AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi-Sankyo, Pfizer, MSD, Sanofi, Taiho Pharmaceutical, and Takeda Pharmaceutical, and personal fees from AstraZeneca, Chugai Pharmaceutical, MSD, and Takeda Pharmaceutical. Dr Gemma reported receiving consulting fees from Nihon Kayaku and personal fees from Daiichi Sankyo and AstraZeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research related to human use has been compiled in accordance with all relevant national regulations and institutional policies, and with the tenets of the Declaration of Helsinki. It has been approved by the authors\u2019 institutional review board or equivalent committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}